<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The objective of this report is to present the results of the BFM group in the treatment of 41 children with non-Hodgkin's B cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and <z:hpo ids='HP_0011009'>acute</z:hpo> B cell lymphoblastic <z:hpo ids='HP_0001909'>leukemia</z:hpo> according to the BFM 86 and 90 protocols </plain></SENT>
<SENT sid="1" pm="."><plain>Forty-one children, between 2 and 16 years of age, were treated from November 1987 to October 1993 </plain></SENT>
<SENT sid="2" pm="."><plain>Of these, 25 were treated with the BFM 86 protocol (18 non-Hodgkin's B cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and 7 <z:hpo ids='HP_0011009'>acute</z:hpo> B cell lymphoblastic <z:hpo ids='HP_0001909'>leukemias</z:hpo>) and the rest with the BFM 90 protocol (15 non-Hodgkin's B cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and 1 <z:hpo ids='HP_0011009'>acute</z:hpo> B cell lymphoblastic <z:hpo ids='HP_0001909'>leukemia</z:hpo>) </plain></SENT>
<SENT sid="3" pm="."><plain>Complete remission was achieved in 97.5% of the patients </plain></SENT>
<SENT sid="4" pm="."><plain>A relapse occurred in 12.5% of the cases </plain></SENT>
<SENT sid="5" pm="."><plain>Currently, 80.4% remain in continuous complete remission and 17% have died </plain></SENT>
<SENT sid="6" pm="."><plain>The 5 year actuarial survival rate of those treated with the BFM 86 and 90 protocols was 79% and 87%, respectively, and event free survival in the same period was 76% and 87%, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>There was no statistically significant difference in the results obtained with the two treatment protocols </plain></SENT>
</text></document>